|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Diabetes Medical Lead
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.29 |
|
|
(ÁÖ)´ÙÀ̾Ƶ§Æ® |
±¹³»¸¶ÄÉÆÃ/¿µ¾÷ ´ã´çÀÚ Ã¤¿ë
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.22 |
|
|
(ÁÖ)¾¾¸Æ¸ÞµðÄ® |
ÀÇ·á±â±â¿µ¾÷»ç¿ø ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.11 |
|
|
Áö¸à½ºÇï½Ã´Ï¾î½º(ÁÖ) |
CT Product Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.23 |
|
|
°¥´õ¸¶ÄÚ¸®¾Æ(ÁÖ) |
PrescriptionºÎ¼ Medical Account Manager ä¿ë
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.29 |
|
|
(ÁÖ)¸ÞµðÅ彺 |
(ÁÖ)¸ÞµðÅ彺 °¢ ºÎ¹®º° ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý
¼¿ï ¼Ãʱ¸, ÃæºÏ û¿ø±º | Çз¹«°ü |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.19 |
|
|
ÀÌÁöÄÚ¾Æ |
ÀÇ·á±â±â ±¹³»¿Ü ÀÎÇã°¡ ¹× ÀÎÁõ, ÀÇ·á±â±âGMP µî RA ¾÷¹«
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.06 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Diabetes Medical Lead
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.30 |
|
|
(ÁÖ)´ëÁø¸Þµð½¼ |
[±¹³»¿µ¾÷ ä¿ë°ø°í] ÇǺΰú,¼ºÇü¿Ü°ú º´.ÀÇ¿ø¿µ¾÷ (½ÅÀÔ/°æ
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.18 |
|
|
(ÁÖ)ÄÚ·»ÅØ |
ÄÚ·»ÅØ ÀÇ·á±â±â SCMÆÀ »ç¿ø ¸ðÁý(¼¿ï±Ù¹«)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.04 |
|
|
¸ÞµðÄ(ÁÖ) |
¸ÞµðÄ(ÁÖ) ¿¬±¸¼Ò¡¤R&D Á¤±ÔÁ÷ ä¿ë
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.16 |
|
|
¸ÞµðÄ(ÁÖ) |
¸ÞµðÄ(ÁÖ) µðÀÚÀÎÆÀ Á¤±ÔÁ÷ ä¿ë °ø°í
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦Ç°/»ê¾÷µðÀÚÀÎ |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.16 |
|
|
´ë¿ìÁ¦¾à(ÁÖ) |
¾È°úPM °æ·ÂÀÚ Ã¤¿ë °ø°í.
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.26 |
|
|
Veeva Systems Korea YH |
Solution Consultant - Vault R&D
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
Account Executive - R&D Vault
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|